VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Solid Tumor · Rhabdomyosarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Elizabeth Sokol, MD) · esokol@luriechildrens.org
Contact: Study coordinator (Laura Schlenker) · lrschlen@luriechildrens.org · 312-227-4003
Contact: Principal Investigator (Elizabeth Sokol, MD)
Boston Children's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Natalie Collins, MD) · nbcollins@partners.org
Contact: Study coordinator (Katherine Moss) · Katherine_moss@dfci.harvard.edu
Contact: Principal Investigator (Natalie Collins, MD)
Cincinnati Children's Hospital, Cincinnati, Ohio, United States
Contact: Study coordinator (Brian Turpin, DO) · cancer@cchmc.org
Contact: Study coordinator (Lori Backus) · cancer@cchmc.org
Contact: Principal Investigator (Brian Turpin, DO)
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Theodore Laetsch, MD) · laetscht@chop.edu
Contact: Study coordinator (Ruchi Singh) · singhr3@chop.edu · 267-425-2187
Contact: Principal Investigator (Theodore Laetsch, MD)
The University of Texas Southwestern Medical Center, Dallas, Texas, United States
Contact: Study coordinator (Arhanti Sadanand, MD) · Arhanti.Sadanand@UTSouthwestern.edu · 214-645-9122
Texas Children's Hospital, Houston, Texas, United States
Contact: Study coordinator (Shoba Navai, MD) · sanavai@texaschildrens.org
Contact: Study coordinator (Kathy McCarthy) · ksmccart@texaschildrens.org
Contact: Principal Investigator (Shoba Navai, MD)
Seattle Children's, Seattle, Washington, United States
Contact: Study coordinator (Katie Albert, MD) · cbdcintake@seattlechildrens.org · 206-987-2106
Contact: Study coordinator (HemOnc CRAs) · HemOncCRAs@seattlechildrens.org
Contact: Principal Investigator (Katie Albert, MD)

Study leads

Arhanti Sadanand, MD
Principal Investigator
University of Texas Southwestern Medical Center

View source on ClinicalTrials.gov Contact study team (email)